Advanced Enzyme Technologies Limited

NSEI:ADVENZYMES Rapport sur les actions

Capitalisation boursière : ₹50.7b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Advanced Enzyme Technologies Bilan de santé

Santé financière contrôle des critères 6/6

Advanced Enzyme Technologies possède un total de capitaux propres de ₹13.7B et une dette totale de ₹473.1M, ce qui porte son ratio d'endettement à 3.5%. Son actif total et son passif total sont ₹15.4B et de ₹1.6B. L'EBIT de Advanced Enzyme Technologies est ₹1.8B ce qui fait que son ratio de couverture des intérêts -17.4. Elle dispose de liquidités et de placements à court terme de ₹5.3B.

Informations clés

3.5%

Ratio d'endettement

₹473.08m

Dette

Ratio de couverture des intérêts-17.4x
Argent liquide₹5.29b
Fonds propres₹13.71b
Total du passif₹1.64b
Total des actifs₹15.35b

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar

Aug 20
After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar

We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now

Jul 19
We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now

Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00

Jul 13
Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00

Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business

Apr 08
Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business

Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Sep 23
Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital

Feb 03
Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital

Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Aug 11
Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting

May 13
With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting

Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture

Mar 28
Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture

The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?

Mar 13
The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?

Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

Feb 21
Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Feb 18
Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut

Feb 03
I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut

What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?

Jan 19
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?

What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?

Dec 28
What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?

The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?

Dec 13
The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?

Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Nov 28
Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?

Nov 20
Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?

Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today

Nov 05
Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today

What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition

Oct 21
What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition

Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Oct 06
Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable

Sep 26
Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable

Our Take On The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES)

Sep 21
Our Take On The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES)

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de ADVENZYMES ( ₹8.1B ) dépassent ses passifs à court terme ( ₹1.1B ).

Passif à long terme: Les actifs à court terme de ADVENZYMES ( ₹8.1B ) dépassent ses passifs à long terme ( ₹580.3M ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: ADVENZYMES dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de ADVENZYMES a été réduit de 5% à 3.5% au cours des 5 dernières années.

Couverture de la dette: La dette de ADVENZYMES est bien couverte par le flux de trésorerie opérationnel ( 298.8% ).

Couverture des intérêts: ADVENZYMES gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.


Bilan


Découvrir des entreprises saines